Literature DB >> 30817281

Long-term outcomes of upper tract urothelial carcinoma: A retrospective evaluation of single-center experience in 275 patients.

Mohamed Mohamed Elawdy1, Yasser Osman1, Diaa Eldin Taha1, Samer El-Halwagy1, Mohamed Abd El-Hamid2, Rasha T Abouelkheir3.   

Abstract

OBJECTIVE: We aimed to report our 25-year experience on upper tract urothelial carcinoma (UTUC) on a larger number of patients with long-term follow-up at a single tertiary urology institute.
MATERIAL AND METHODS: A retrospective study was conducted on 275 patients from 1990 to 2015. Basic patient demographic data with the laboratory and radiologic investigations were collected. We used 1997 TNM classification and the three-tiered WHO grading system. Data were collected using an SPSS® version 21 spreadsheet.
RESULTS: The mean age was 59±11 years, and 88% of all the patients were male. Previous and concurrent bladder tumors were found in 16% and 26%, respectively. Computed tomography gave an overall accuracy of 96%. Open nephroureterectomy and bladder cuff excision was performed for 85%, and the remaining by laparoscopy and nephron-sparing surgeries. Tumor was pelvicalyceal, ureteric, and both in 40%, 40%, and 20% respectively. In 97% of the patients, the tumor was transitional cell carcinoma. Nearly two-thirds of the patients were of low grade and non-invasive in stage. Nearly half of the patients (46%) had bladder tumor recurrence after NU. Bladder, urethral, and contralateral recurrence, distant, local metastasis occurred in 46%, 2%, 1%, 7.5%, and 6%, respectively.
CONCLUSION: UTUC is a unique disease with synchronous and metachronous urothelial tumor recurrence that requires long-term surveillance. The majority (two-thirds) of the patients are non-invasive in stage of grade II. Tumor stage is of paramount prognostic significance for survival; the five-year survival rate of T1 and T4 is 80% and 0%, respectively.

Entities:  

Year:  2019        PMID: 30817281      PMCID: PMC6469729          DOI: 10.5152/tud.2019.02185

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  21 in total

1.  Transitional cell carcinoma of the kidney 25-year experience.

Authors:  M A Rubenstein; B J Walz; J G Bucy
Journal:  J Urol       Date:  1978-05       Impact factor: 7.450

2.  Impact of Ureteroscopy Before Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes.

Authors:  Alexander Sankin; Amy L Tin; Roy Mano; Michael Chevinsky; Chris Jakubowski; John P Sfakianos; Eugene K Cha; Alyssa Yee; Fara M Friedman; Daniel D Sjoberg; Behfar Ehdaie; Jonathan Coleman
Journal:  Urology       Date:  2016-05-26       Impact factor: 2.649

3.  Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach.

Authors:  E Guarnizo; C P Pavlovich; M Seiba; D L Carlson; E D Vaughan; R E Sosa
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

Review 4.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.

Authors:  Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard J Sylvester; Maximilian Burger; Nigel C Cowan; Paolo Gontero; Bas W G Van Rhijn; A Hugh Mostafid; Joan Palou; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2017-09-01       Impact factor: 20.096

5.  Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.

Authors:  Sten Holmäng; Subodh M Lele; Sonny L Johansson
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

6.  Tumors of the upper urinary tract: 10 years of experience.

Authors:  L Charbit; M C Gendreau; S Mee; J Cukier
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

7.  Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

Authors:  M C Hall; S Womack; A I Sagalowsky; T Carmody; M D Erickstad; C G Roehrborn
Journal:  Urology       Date:  1998-10       Impact factor: 2.649

Review 8.  Is Ureteroscopy Needed Prior to Nephroureterectomy? An Evidence-Based Algorithmic Approach.

Authors:  Aaron M Potretzke; B Alexander Knight; Theodora A Potretzke; Jeffrey A Larson; Sam B Bhayani
Journal:  Urology       Date:  2015-11-03       Impact factor: 2.649

9.  Elective segmental ureterectomy for transitional cell carcinoma of the ureter: long-term follow-up in a series of 73 patients.

Authors:  Alchiede Simonato; V Varca; A Gregori; A Benelli; M Ennas; A Lissiani; M Gacci; S De Stefani; M Rosso; S Benvenuto; G Siena; E Belgrano; F Gaboardi; M Carini; G Bianchi; G Carmignani
Journal:  BJU Int       Date:  2012-11-07       Impact factor: 5.588

10.  Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience.

Authors:  Mohamed Mohamed Elawdy; Yasser Osman; Diaa Eldin Taha; Mohamed H Zahran; Samer El-Halwagy; Muftah El Garba; Ahmed M Harraz
Journal:  Arab J Urol       Date:  2017-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.